Lung organoids are 3D models that mimic the cellular diversity and functional structures of natural lungs.
They self-organize and can be utilized for disease modeling, providing insights into various lung conditions.
Lung organoids are valuable for drug testing, allowing researchers to assess drug efficacy and potential toxicity.
They can be genetically manipulated for studying specific genes and molecular mechanisms related to lung development and diseases.
Lung organoid
Fibrosis is a disease characterized by repetitive injury and inflammation.
Lambda provides a lung and intestine fibrosis organoid model, enabling drug development and efficacy assessment.
Cell Type
· ASC
Assay
· Idiopathic pulmonary fibrosis
As a virus-infected model, the
utilization of tonsil, adenoid, and lung organoids allows for the evaluation of antiviral drug efficacy and facilitates virus research.
Cell Type
· iPSC
· ASC
Assay
· Respiratory tract infection
· SARS-COV-2 infection model
Lambda Biologics GmbH
Deutscher Pl. 5c, 04103 Leipzig, Germany
